FarmaKeio Custom Compounding recently announced the acquisition of its newest location in Conway. The new facility is a $2.29 million investment for FarmaKeio, and is expected to bring 74 new jobs to the area.
“This state-of-the-art facility signifies our unwavering commitment to personalized patient care. We are excited about the possibilities this facility brings and are optimistic about its potential to further enhance our ability to positively impact patient lives,” said Dan DeNeui, CEO of FarmaKeio.
The 16,000-square-foot Conway facility will provide more space for not only service and product lines but also research, testing and development. It boasts advanced compounding and laboratory equipment, ample office space and large production areas, including sterile and non-sterile work areas and a warehouse for storage.
“Congratulations to FarmaKeio on the acquisition of its newest facility in Arkansas and congratulations to the team in Conway for securing this major investment,” said Governor Sarah Huckabee Sanders. “This announcement brings millions of dollars and dozens of jobs to Arkansas’s fastest-growing city. It’s a win for the community, a win for the business and a win for our state. In my administration, we’re doing everything we can to make announcements like this regular by cutting taxes, investing in education and building up a robust workforce.”
To learn more about the new FarmaKeio facility, click here.
READ ALSO: STANDARD LITHIUM FILES FEASIBILITY STUDY FOR ARKANSAS FACILITY
